Abstract
BACKGROUND: Heart failure is a serious, common, and growing problem. Hospital admissions, which account for the bulk of health service costs associated with heart failure, are becoming more frequent. AIM: To determine whether management of heart failure differs by age and sex. METHOD: A retrospective case note review of prevalent cases in 16 general practices in West London. Five hundred and eighty-three patients (57% women) with a diagnosis of heart failure were reviewed. RESULTS: Mean age of patients with heart failure was 78 years (SD = 9.5)--74 years at diagnosis (SD = 10)--and was higher for women than men (76 years versus 71 years, P < 0.001). In 32% of patients there was no record of a chest X-ray, electrocardiogram, or echocardiogram to support diagnosis. Echocardiography, performed in 34% of patients, was less likely in older patients in both sexes (test for trend P = 0.04 in women and 0.02 in men) and, overall, in women (29% compared with 40% of men, P = 0.006). Angiotensin-converting enzyme (ACE) inhibitor treatment, recorded in 54% of patients, decreased with age in both sexes (P < 0.001) and, on unadjusted data, was more likely in men than in women (61% compared with 49%, P = 0.005). On adjustment for age, sex differences in the use of echocardiography and ACE inhibitors were reduced and no longer significant. CONCLUSIONS: With increasing age, men and women with heart failure were less likely to have undergone echocardiography or to have received an ACE inhibitor. When account was taken of age, there were no statistically significant sex differences in management; however, because of the demographic distribution of heart failure, women are disproportionately affected by age differences in management. Clinical trials, physician practice, and service developments in heart failure have neglected older people. This balance should be redressed.
Full Text
The Full Text of this article is available as a PDF (50.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ayanian J. Z., Epstein A. M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991 Jul 25;325(4):221–225. doi: 10.1056/NEJM199107253250401. [DOI] [PubMed] [Google Scholar]
- Bourassa M. G., Gurné O., Bangdiwala S. I., Ghali J. K., Young J. B., Rousseau M., Johnstone D. E., Yusuf S. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):14A–19A. doi: 10.1016/0735-1097(93)90456-b. [DOI] [PubMed] [Google Scholar]
- Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
- Ghali J. K., Cooper R., Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med. 1990 Apr;150(4):769–773. [PubMed] [Google Scholar]
- Haffner C. A., Kendall M. J., Struthers A. D., Bridges A., Stott D. J. Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure. Postgrad Med J. 1995 May;71(835):287–292. doi: 10.1136/pgmj.71.835.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall A. S., Murray G. D., Ball S. G. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. Lancet. 1997 May 24;349(9064):1493–1497. doi: 10.1016/s0140-6736(97)04442-5. [DOI] [PubMed] [Google Scholar]
- Heck I., Lüderitz B., Müller H. M., Esser H. A comparison of captopril and digoxin in the treatment of patients with mild-to-moderate chronic congestive heart failure. Clin Ther. 1995 Mar-Apr;17(2):270–279. doi: 10.1016/0149-2918(95)80025-5. [DOI] [PubMed] [Google Scholar]
- Ho K. K., Anderson K. M., Kannel W. B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993 Jul;88(1):107–115. doi: 10.1161/01.cir.88.1.107. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Belanger A. J. Epidemiology of heart failure. Am Heart J. 1991 Mar;121(3 Pt 1):951–957. doi: 10.1016/0002-8703(91)90225-7. [DOI] [PubMed] [Google Scholar]
- Lang R. M., DiBianco R., Broderick G. T., Gottlieb S. S., Kostis J., Lyle P. A., Makris L., Rajfer S. I., Rucinska E. J. First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators. Am Heart J. 1994 Sep;128(3):551–556. doi: 10.1016/0002-8703(94)90631-9. [DOI] [PubMed] [Google Scholar]
- Mair F. S., Crowley T. S., Bundred P. E. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract. 1996 Feb;46(403):77–79. [PMC free article] [PubMed] [Google Scholar]
- McMurray J., McDonagh T., Morrison C. E., Dargie H. J. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993 Sep;14(9):1158–1162. doi: 10.1093/eurheartj/14.9.1158. [DOI] [PubMed] [Google Scholar]
- Parameshwar J., Shackell M. M., Richardson A., Poole-Wilson P. A., Sutton G. C. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract. 1992 Jul;42(360):287–289. [PMC free article] [PubMed] [Google Scholar]
- Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
- Philbin E. F., Andreaou C., Rocco T. A., Lynch L. J., Baker S. L. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996 Apr 15;77(10):832–838. doi: 10.1016/s0002-9149(97)89177-1. [DOI] [PubMed] [Google Scholar]
- Pilote L., Miller D. P., Califf R. M., Rao J. S., Weaver W. D., Topol E. J. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med. 1996 Oct 17;335(16):1198–1205. doi: 10.1056/NEJM199610173351606. [DOI] [PubMed] [Google Scholar]
- Remes J., Reunanen A., Aromaa A., Pyörälä K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J. 1992 May;13(5):588–593. doi: 10.1093/oxfordjournals.eurheartj.a060220. [DOI] [PubMed] [Google Scholar]
- Senni M., Rodeheffer R. J., Tribouilloy C. M., Evans J. M., Jacobsen S. J., Bailey K. R., Redfield M. M. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol. 1999 Jan;33(1):164–170. doi: 10.1016/s0735-1097(98)00523-3. [DOI] [PubMed] [Google Scholar]
- Senni M., Tribouilloy C. M., Rodeheffer R. J., Jacobsen S. J., Evans J. M., Bailey K. R., Redfield M. M. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998 Nov 24;98(21):2282–2289. doi: 10.1161/01.cir.98.21.2282. [DOI] [PubMed] [Google Scholar]
- Stewart A. L., Greenfield S., Hays R. D., Wells K., Rogers W. H., Berry S. D., McGlynn E. A., Ware J. E., Jr Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989 Aug 18;262(7):907–913. [PubMed] [Google Scholar]
- Tobin J. N., Wassertheil-Smoller S., Wexler J. P., Steingart R. M., Budner N., Lense L., Wachspress J. Sex bias in considering coronary bypass surgery. Ann Intern Med. 1987 Jul;107(1):19–25. doi: 10.7326/0003-4819-107-1-19. [DOI] [PubMed] [Google Scholar]